You are here

Rubius Therapeutics to Participate at Upcoming Investor Conferences

CAMBRIDGE, Mass., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biopharmaceutical company that is generating red blood cells and bioengineering them into an entirely new class of cellular medicines, today announced that Pablo J. Cagnoni, M.D., chief executive officer, will participate at the following investor conferences:
Tuesday, February 19, 2019 - 16:05